Found 5 matching trials
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201) PHASE1 This study will check how well a new medicine, Risvutatug rezetecan, (Ris-R...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103) PHASE1 This is an early-phase clinical study investigating a new combination treat...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD) PHASE1 The goal of this study is to assess the safety, tolerability, clinical acti...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) PHASE3 In this study researchers are testing Risvutatug rezetecan also known as (R...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202) PHASE1 The main goal of this study is to test a new medicine, Risvutatug Rezetecan...
Show More Location
GSK Investigational Site
Learn More & Join Trial